Literature DB >> 18559584

Patient perspectives on phase 0 clinical trials.

Martin Gutierrez1, Deborah Collyar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559584     DOI: 10.1158/1078-0432.CCR-07-4561

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  5 in total

Review 1.  A Review on: Phase '0' Clinical Trials or Exploratory Investigational New Drug.

Authors:  Ashish A Gawai; Faisal Shaikh; Mangesh Gadekar; Nitin Deokar; Shivanand Kolhe; K R Biyani
Journal:  Turk J Pharm Sci       Date:  2017-04-15

2.  Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies.

Authors:  Shivaani Kummar; Robert Kinders; Martin E Gutierrez; Larry Rubinstein; Ralph E Parchment; Lawrence R Phillips; Jiuping Ji; Anne Monks; Jennifer A Low; Alice Chen; Anthony J Murgo; Jerry Collins; Seth M Steinberg; Helen Eliopoulos; Vincent L Giranda; Gary Gordon; Lee Helman; Robert Wiltrout; Joseph E Tomaszewski; James H Doroshow
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

3.  Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient.

Authors:  James H Doroshow; Ralph E Parchment
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

4.  Phase 0 clinical trials in oncology new drug development.

Authors:  Umesh Chandra Gupta; Sandeep Bhatia; Amit Garg; Amit Sharma; Vaibhav Choudhary
Journal:  Perspect Clin Res       Date:  2011-01

5.  Phase 0 clinical trials: towards a more complete ethics critique.

Authors:  T Patrick Hill
Journal:  Ecancermedicalscience       Date:  2012-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.